Objectives To evaluate prospectively the effect of weight loss on the achievement of minimal
disease activity (MDA) in overweight/obese patients with psoriatic arthritis (PsA) starting …

Objective We prospectively evaluated whether obesity impacts achievement of minimal
disease activity (MDA) in subjects with psoriatic arthritis (PsA). Methods Among PsA subjects …

Objective— Subjects with psoriatic arthritis (PsA) have an abnormally high prevalence of
vascular risk factors (VRFs) and are predisposed to vascular mortality. Tumor necrosis factor (…

OBJECTIVE: To study distal interphalangeal (DIP) joints in patients with psoriatic arthritis (PsA)
with or without onychopathy, using magnetic resonance imaging (MRI). METHODS: …

OBJECTIVE: To characterize the clinical pattern of early psoriatic arthritis (PsA). METHODS:
We studied 47 consecutive patients: 29 had definite PsA and 18 had the "sine psoriasis" …

PsA is an axial and/or peripheral inflammatory arthritis associated with psoriasis, included in
the group of spondylarthritides. It has been suggested that PsA could be a systemic disease…

Enteropathic arthritis (EA) is a spondyloarthritis (SpA) which occurs in patients with
inflammatory bowel diseases (IBDs) and other gastrointestinal diseases. Diagnosis is generally …

Thirty-five patients with Early Psoriatic Arthritis (EPA) (17 female and 18 male; mean age 25.6
years) entered this randomised 6-month study. At the enrolment, all patients were on non-…

Psoriatic arthritis (PsA) is an inflammatory rheumatic disorder, associated with skin and/or
nail psoriasis. It has been included in the spondyloarthropathies (SpA) group, with which it …

The aim of this study is to compare effectiveness and safety of Infliximab (INF), Etanercept (ETN),
and Adalimumab (ADA) in patients with psoriatic arthritis (PsA) with inadequate …